Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CEFAMANDOLE NAFATE
Eli Lilly and Company Limited
CEFAMANDOLE NAFATE
500 Milligram
Pdr for Soln for Injection
Withdrawn
2007-11-01
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Kefadol 0.5g, Powder for Solution for Injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 500 mg (0.5 g) of cefamandole (as cefamandole nafate). For excipients, see 6.1. 3 PHARMACEUTICAL FORM Powder for solution for injection A white to off-white, sterile, crystalline powder. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cefamandole is indicated in the treatment of infections of the lower respiratory tract, genito-urinary tract, bones and joints, bloodstream (septicaemia), skin and soft tissue, gall bladder and peritoneum, and pelvic inflammatory disease in women, when due to susceptible micro-organisms. Prophylactic use: Perioperative administration of cefamandole may reduce the incidence of postoperative infections in patients undergoing contaminated or potentially contaminated surgical procedures associated with a high risk of infection, or where the occurrence of a postoperative infection could be especially serious. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Cefamandole nafate may be given intravenously or by deep intramuscular injection into a large muscle mass to minimise pain. Adults and the elderly: The dosage range for cefamandole is 500mg to 2g every four to eight hours, depending on the severity and site of infection. Impaired renal function: When renal function is impaired, a reduced dosage must be employed and serum concentrations should be monitored when feasible. After an initial dose of 1 to 2g (depending on the severity of infection), a maintenance dosage schedule should be followed (see table). Continued dosage should be determined by degree of renal impairment, severity of infection and susceptibility of the causative organism. IRISH MEDICINES BOARD ________________________ Read the complete document